These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20498714)

  • 21. The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions.
    Matthew EM; Hart LS; Astrinidis A; Navaraj A; Dolloff NG; Dicker DT; Henske EP; El-Deiry WS
    Cell Cycle; 2009 Dec; 8(24):4168-75. PubMed ID: 20054236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.
    Cirstea D; Hideshima T; Rodig S; Santo L; Pozzi S; Vallet S; Ikeda H; Perrone G; Gorgun G; Patel K; Desai N; Sportelli P; Kapoor S; Vali S; Mukherjee S; Munshi NC; Anderson KC; Raje N
    Mol Cancer Ther; 2010 Apr; 9(4):963-75. PubMed ID: 20371718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism.
    Yu S; Shen G; Khor TO; Kim JH; Kong AN
    Mol Cancer Ther; 2008 Sep; 7(9):2609-20. PubMed ID: 18790744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-concentration DMSO accelerates skin wound healing by Akt/mTOR-mediated cell proliferation and migration in diabetic mice.
    Guo W; Qiu W; Ao X; Li W; He X; Ao L; Hu X; Li Z; Zhu M; Luo D; Xing W; Xu X
    Br J Pharmacol; 2020 Jul; 177(14):3327-3341. PubMed ID: 32167156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI
    Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
    Xu G; Zhang W; Bertram P; Zheng XF; McLeod H
    Int J Oncol; 2004 Apr; 24(4):893-900. PubMed ID: 15010827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
    Cloughesy TF; Yoshimoto K; Nghiemphu P; Brown K; Dang J; Zhu S; Hsueh T; Chen Y; Wang W; Youngkin D; Liau L; Martin N; Becker D; Bergsneider M; Lai A; Green R; Oglesby T; Koleto M; Trent J; Horvath S; Mischel PS; Mellinghoff IK; Sawyers CL
    PLoS Med; 2008 Jan; 5(1):e8. PubMed ID: 18215105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expressions of the key proteins of the protein kinase B/mammalian target of rapamycin signaling pathway in skin tissue and wound tissue of diabetic rats].
    Huang H; Qiu W; Zhu M; Zhang Y; Cui WH; Xing W; Li XY; An TC; Chen MJ; Guo W; Xu X
    Zhonghua Shao Shang Za Zhi; 2016 Oct; 32(10):588-593. PubMed ID: 27765089
    [No Abstract]   [Full Text] [Related]  

  • 31. Electric field-induced suppression of PTEN drives epithelial-to-mesenchymal transition via mTORC1 activation.
    Yan T; Jiang X; Guo X; Chen W; Tang D; Zhang J; Zhang X; Zhang D; Zhang Q; Jia J; Huang Y
    J Dermatol Sci; 2017 Feb; 85(2):96-105. PubMed ID: 27919618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.
    Neshat MS; Mellinghoff IK; Tran C; Stiles B; Thomas G; Petersen R; Frost P; Gibbons JJ; Wu H; Sawyers CL
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10314-9. PubMed ID: 11504908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN: a promising pharmacological target to enhance epithelial wound healing.
    Zhao M
    Br J Pharmacol; 2007 Dec; 152(8):1141-4. PubMed ID: 17922021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
    Cao X; Kambe F; Moeller LC; Refetoff S; Seo H
    Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.
    Alayev A; Salamon RS; Schwartz NS; Berman AY; Wiener SL; Holz MK
    J Cell Physiol; 2017 Feb; 232(2):436-446. PubMed ID: 27225870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PTEN inhibition improves wound healing in lung epithelia through changes in cellular mechanics that enhance migration.
    Mihai C; Bao S; Lai JP; Ghadiali SN; Knoell DL
    Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(3):L287-99. PubMed ID: 22037358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GSK3 and its interactions with the PI3K/AKT/mTOR signalling network.
    Hermida MA; Dinesh Kumar J; Leslie NR
    Adv Biol Regul; 2017 Aug; 65():5-15. PubMed ID: 28712664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Boesenbergia rotunda extract accelerates human keratinocyte proliferation through activating ERK1/2 and PI3K/Akt kinases.
    Ruttanapattanakul J; Wikan N; Okonogi S; Na Takuathung M; Buacheen P; Pitchakarn P; Potikanond S; Nimlamool W
    Biomed Pharmacother; 2021 Jan; 133():111002. PubMed ID: 33212374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.
    Albert S; Serova M; Dreyer C; Sablin MP; Faivre S; Raymond E
    Expert Opin Investig Drugs; 2010 Aug; 19(8):919-30. PubMed ID: 20569080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolidase Stimulates Proliferation and Migration through Activation of the PI3K/Akt/mTOR Signaling Pathway in Human Keratinocytes.
    Misiura M; Baszanowska W; Ościłowska I; Pałka J; Miltyk W
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.